Zurueck zur Suche

Reporte zur Charge U017524

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

27Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WA 4 CA 3 NM 2 ID 2 OR 2 KY 1 UT 1 AZ 1 IL 1 DC 1 MD 1 PA 1

VAERS 2519965

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

moderat
Staat
-
Alter
1,1
Geschlecht
M
Eingang
30.11.2022
Impfdatum
01.11.2022
Beginn
03.11.2022
Tage bis Beginn
2,0
Dosis
2
Route/Site
SC / LG
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Injection site pruritus Papule Pyrexia Tremor

Symptomtext

fevers with shaking (unlikely seizures based on description) followed by itching at site of injection and diffusely scattered papules

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
unknown, possible allergic reactions to nuts
Vorherige Impfungen
-

VAERS 2178029

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u017524

moderat
Staat
KY
Alter
43,0
Geschlecht
F
Eingang
14.03.2022
Impfdatum
10.03.2022
Beginn
10.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bone pain Laboratory test Neck pain Pain Paraesthesia

Symptomtext

Soreness, tingling in left hand and left foot, bone pain, neck pain

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Labs drawn 03/14/2022 at Center
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2630841

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

mild
Staat
NM
Alter
1,3
Geschlecht
U
Eingang
11.05.2023
Impfdatum
18.04.2023
Beginn
30.04.2023
Tage bis Beginn
12,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cough Ear infection Pyrexia Rash Rash erythematous Respiratory tract congestion

Symptomtext

16 month-old here with mother for follow-up on ear infection. Had completed antibiotics x 10 days and no issues at this time. (+) MMR, varicella - given on 4/19/2023 4 days ago, had fever x 2 days and then on third day, had erythematous rash that started on the face and spread to the trunk and extremities. (+) cough and congestion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
3/10/23 R Bacterial conjunctivitis
Vorgeschichte
None
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2568690

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

mild
Staat
CA
Alter
1,2
Geschlecht
F
Eingang
26.01.2023
Impfdatum
26.01.2023
Beginn
26.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling

Symptomtext

Patient received 12 month vaccines. Had patient wait 10-15 mins after vaccines were given. Checked patient at 10:40, and noticed patient had redness and slight swelling on right thigh where Varicella vaccine was administered. Called primary provider to get a second look and opinion on thigh. Provider prescribed Benadryl for mild reaction to Varicella vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2490420

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

mild
Staat
UT
Alter
1,0
Geschlecht
M
Eingang
26.10.2022
Impfdatum
08.06.2022
Beginn
08.10.2022
Tage bis Beginn
122,0
Dosis
1
Route/Site
SC / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Blister Haemorrhage Herpes zoster Pain Polymerase chain reaction positive Pustule Rash erythematous Skin lesion Varicella virus test positive

Symptomtext

Developed lesions on the right leg that started 10/8/22 or 10/9/22. Grouped pustules and hemorrhagic vesicles on an erythematous base in a dermatomal distribution with viral PCR positive for VZV consistent with herpes zoster infection. No history of chickenpox but did receive first dose of varicella vaccine approximately 4 months prior. Was given IV acyclovir, treated for aggressive pain control with ice packs/cool compresses and systemic analgesics.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
10/10/2022 - lesion positive for varicella zoster virus (VZV) by PCR
Aktuelle Erkrankungen
-
Vorgeschichte
PCP concern for immunodeficiency. Congenital dermal melanocytosis. Third admission in a year (febrile UTI, COVID, PNA).
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2331841

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

mild
Staat
AZ
Alter
1,0
Geschlecht
F
Eingang
24.06.2022
Impfdatum
13.06.2022
Beginn
23.06.2022
Tage bis Beginn
10,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

Rash started on forehead on 6/23/2022 and spread to stomach and arms morning of 6/24/2022 when patient was seen in office.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-

VAERS 2259853

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

mild
Staat
IL
Alter
-
Geschlecht
U
Eingang
28.04.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site rash Rash Rash erythematous Rash papular

Symptomtext

Rash started about 12 days after vaccine - papulovesicular rash with slight erythema 8cm x 4cm at injection site R thigh. Spread to trunk after onset

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
mild persistent reactive airway disease J45.30
Vorgeschichte
-
Andere Medikamente
Budesonide 0.5mg/2ml Albuterol 1.25mg/3ml
Allergien
none
Vorherige Impfungen
-

VAERS 2653824

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
DC
Alter
-
Geschlecht
U
Eingang
08.07.2023
Impfdatum
30.06.2023
Beginn
30.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse effects; Nurse called regarding MMR II. Nurse reported expired vaccine was administered to a patient. Patient is not reporting signs or symptoms of adverse effects. Expiration date for lot # U017524 was 06/03/2023. Permission to contact HCP was granted. No ad; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's historical medications, medical history, concurrent conditions and concomitant medications were not reported. On 30-JUN-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) lot number U017524, expiration date 03-JUN-2023 (dose and route of administration not reported) for prophylaxis (expired product administered). No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2651983

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U017524

gering
Staat
MD
Alter
1,0
Geschlecht
F
Eingang
03.07.2023
Impfdatum
30.06.2023
Beginn
30.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

Patient received expired MMR vaccine during well child clinic visit. No adverse reactions experienced. Provider and parent was notified.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Iron
Allergien
None
Vorherige Impfungen
-

VAERS 2646519

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u017524

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
16.06.2023
Impfdatum
09.06.2023
Beginn
09.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs were reported.; an expired dose of MMR II vaccine was administered to a patient; This spontaneous report was received from a medical assistant referring to a patient of unknown gender and age. The patient's medical history, concurrent conditions or concomitant therapies were not reported. On 09-JUN-2023, the patient was vaccinated with 1 dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, lot #u017524, expiration date: 03-JUN-2023 (strength, route of administration, and indication were not provided) (expired product administered). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2645140

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
NM
Alter
1,0
Geschlecht
M
Eingang
14.06.2023
Impfdatum
07.06.2023
Beginn
07.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; HCP called to report inadvertent administration of an expired dose of MMR II. MMR II expired on 6/3/2023 and was administered on 6/7/2023.; This spontaneous report was received from a registered nurse referring to a 12-month-old male patient. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 07-JUN-2023, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (rHA) injection (0.5 ml, lot#: U017524, expiration date: 03-JUN-2023; strength was not reported) orally for prophylaxis (expired product administered). No adverse effects were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2643588

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
14.06.2023
Impfdatum
09.06.2023
Beginn
09.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE/PQC.; Caller reported inadvertent administration of MMR-II 6 days post-expiry; This spontaneous report has been received from a medical assistant regarding a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided. On 09-JUN-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, 0.5 milliliters (ml) and sterile diluent (dose number, frequency, vaccination scheme, route of administration, anatomical location, lot number, and expiration date were not provided) 6 days post-expiry (expired product administered) with no known temperature excursion (TE). No reported symptoms at time of call. No additional adverse event (AE).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2642219

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
07.06.2023
Impfdatum
05.06.2023
Beginn
05.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported.; Expired dose of MMR II was administered to a pediatric patient today.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information on patient's medical history, current conditions and concomitant medications was provided. On 05-JUN-2023, the patient was vaccinated with dose of expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot #U017524 and expiration date 03-JUN-2023, 0.5 milliliter for prophylaxis (route of administration, strength and dose number were not provided) (expired product administered and adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2597180

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
ID
Alter
-
Geschlecht
U
Eingang
16.03.2023
Impfdatum
17.02.2023
Beginn
17.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

no adverse event; A pharmacist reported that a dose of MMR II vaccine was administered to a patient via the intramuscular route instead of the subcutaneous route; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported. On 17-FEB-2023, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant Human albumin (rHA) (M-M-R II) use as directed to prevent measles, mumps and rubella infection as prophylaxis, lot #U017524, expiration date: 03-JUN-2023 (strength was not provided), via the intramuscular route instead of the subcutaneous route (incorrect route of product administration). There was no additional adverse event (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2590332

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
AK
Alter
1,0
Geschlecht
F
Eingang
02.03.2023
Impfdatum
27.01.2023
Beginn
27.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

Infanrix vaccine administered prior to four to six month interval. Administered at 3mo, 1weeks. No adverse reaction from patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2583207

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
17.02.2023
Impfdatum
06.02.2023
Beginn
06.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event

Symptomtext

No additional AE or PQC reported; HCP reported MMR II was inadvertently administered with PROQUAD. No additional AE or PQC reported. No additional information provided.; This spontaneous report was received from a nurse and refers to a patient of unspecified age and gender. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 06-FEB-2023, the patient was inadvertently vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) subcutaneous injection, lot #U017524, expiration date: 03-JUN-2023 (strength, and route of administration were not provided) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) subcutaneous injection, lot #W017572, expiration date: 29-NOV-2023 (strengths, doses, vaccination schedules, sites and route of administration were not provided) for prophylaxis (Accidental overdose). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574475

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
-
Alter
1,0
Geschlecht
M
Eingang
02.02.2023
Impfdatum
19.01.2023
Beginn
21.01.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Balance disorder Decreased appetite Developmental regression Fall Gait disturbance Irritability Orthostatic intolerance Sleep disorder

Symptomtext

Regression of walking, unsteadiness standing and while cruising or stepping (improved 1/31) Tendency for falling backwards Intolerance of being brought down to supine position (resolved on 1/30) Reduced appetite for solids and reduced appetite for milk (improved 2/1) Irregular sleep pattern Fussy

Weitere VAERSDATA-Felder
Praegender Schweregrund
Balance disorder
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Vitamin D intermittently, stopped since the 19th. They were focusing on outdoor time instead. Topical antifungal (MUAid) started 30th
Allergien
none
Vorherige Impfungen
colic, pediarix at age 3 months

VAERS 2568604

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
CA
Alter
1,1
Geschlecht
F
Eingang
26.01.2023
Impfdatum
25.01.2023
Beginn
25.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Swelling

Symptomtext

Patient had slight swelling and redness. Was given 2.5mL of12.5mg/5mL of Benadryl P.O x1 in office. Lot: 1HK0857 EXP: 06/2023

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2561431

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
WA
Alter
14,0
Geschlecht
F
Eingang
17.01.2023
Impfdatum
17.01.2023
Beginn
17.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

patient should have received Tdap but instead received Dtap.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2559596

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
ID
Alter
1,2
Geschlecht
M
Eingang
13.01.2023
Impfdatum
13.01.2023
Beginn
13.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Needle issue Syringe issue

Symptomtext

Needle was not in all the way and gave vaccine. However, vaccine liquid leaked through between needle and syringe.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Needle issue
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2537164

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
WA
Alter
2,0
Geschlecht
F
Eingang
20.12.2022
Impfdatum
28.11.2022
Beginn
28.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental underdose No adverse event Product administered to patient of inappropriate age Underdose

Symptomtext

No additional AE reported; during administration of MMR II dose, patient moved her leg and she only received about half the dose; This spontaneous report was received from a medical assistant student and refers to a 2-year-old female patient. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 28-NOV-2022, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) subcutaneous injection, 0.5 ml, lot # U017524, expiration date: 03-JUN-2023, administered for prophylaxis (strength, and route of administration were not provided) reconstituted with a sterile diluent (Inappropriate age at vaccine administration). During administration of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) dose, the patient moved her leg and she only received about half the dose (Accidental underdose). Agent confirmed there was nothing wrong with the product. No additional AE reported. This is one of 2 reports received from the same reporter.; Sender's Comments: US-009507513-2212USA000351:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2480836

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
CA
Alter
1,3
Geschlecht
F
Eingang
17.10.2022
Impfdatum
21.09.2022
Beginn
21.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

patient had no Symptoms

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2466134

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
OR
Alter
1,0
Geschlecht
M
Eingang
30.09.2022
Impfdatum
30.09.2022
Beginn
30.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products

Symptomtext

CMA accidentally administered Pfizer as second dose in COVID vaccine series when patient received Moderna as first dose. First dose of Moderna vaccine administered on 7/23/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2412846

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
WA
Alter
0,9
Geschlecht
M
Eingang
16.08.2022
Impfdatum
16.08.2022
Beginn
16.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

No adverse symptoms noted. Vaccines were administered five days earlier than minimum valid date. Provider in office was notified. Father was also notified while in office and advised vaccines will need to be given again. Father educated to monitor for signs of adverse reactions and advised to report them. Father verbalized understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2307014

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
VA
Alter
1,9
Geschlecht
F
Eingang
02.06.2022
Impfdatum
01.06.2022
Beginn
02.06.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Pt received extra dose of Varicella, MMR, and PCV13

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
NONE
Andere Medikamente
UKNOWN
Allergien
NKA
Vorherige Impfungen
-

VAERS 2204344

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u017524

gering
Staat
-
Alter
46,0
Geschlecht
M
Eingang
29.03.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect route of product administration

Symptomtext

Vaccination completed IM instead of SC on patient's right arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2137140

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U017524

gering
Staat
OR
Alter
4,0
Geschlecht
F
Eingang
24.02.2022
Impfdatum
23.02.2022
Beginn
24.02.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Computerised tomogram head Electrocardiogram Full blood count Hypotonia Unresponsive to stimuli Urine analysis

Symptomtext

Patient was found unresponsive at 6:00am this morning when mom went to wake her for the day. She was limp, breathing normally, and taken immediately to the local Emergency Room when she finally came around after a little while. Further work up/evaluation is currently being done

Weitere VAERSDATA-Felder
Praegender Schweregrund
Computerised tomogram head
Hospital-Tage
-
Labordaten
CBC, Urinalysis, Head CT, EKG 2/24/2022 Other tests possibly pending depending on results and patient
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-